期刊文献+

口服降糖药应用分析 被引量:2

Analysis of Oral Hypoglycemic Drugs Used in Hospital
下载PDF
导出
摘要 目的了解2007~2008年常州市中医医院糖尿病药物病区的使用情况及趋势,为临床合理用药及科学管理提供参考。方法采用金额排序法和DDDs排序法,利用电子表格excel2000对该医院近2年口服降糖药的用药金额、主要品种及其DDDs进行统计分析。结果2年来该院口服降血糖药用药金额和DDDs呈下降趋势,最常用的降糖药为马来酸罗格列酮、阿卡波糖,国产降血糖药的用药金额增幅明显。结论该院近2年口服降血糖药的用药趋势下降,安全有效、价格适中的国产降血糖药具有广阔的前景。 Objective To understand the application and trend of oral hypolycemic drugs in the ChangZhou hospital during the period of 2007 - 2008. Methods To statistically analyzethe sum of money and DDDs of dominating oral hypoglycemic drugs of this hospitalin recent 2 years. Results The puichase cost and frequency usage of oral hypoglycemic drugs declined during 2 years ; Cinepazide Maleate and acarbose were the leading drugs in this hospital ; the purchase cost of the drugs manufactured at home presented a significant increase. Conclusion The use of oral hypoglycemic drugs in this hospital isapproximately dicreased in recent 2 years and the future for drugs of safe, effective and cheap manufactured at home is bright in China.
作者 张晶
机构地区 常州市中医医院
出处 《常州实用医学》 2010年第1期34-36,共3页 CHANGZHOU PRACTICAL MEDICINE
关键词 降血糖药 DDDS 药物经济学 oral hypoglycemic drugs DDDs phamaco - economics
  • 相关文献

参考文献7

二级参考文献37

  • 1刘芳,徐火根,姚庆姑,徐东丽,陈影,谢连红.二甲双胍可降低超重和单纯性肥胖患者的瘦素水平[J].复旦学报(医学版),2003,30(3):251-254. 被引量:14
  • 2谢洁琼,吕秋军.抗2型糖尿病药物作用靶点的研究进展[J].国外医学(药学分册),2005,32(2):105-109. 被引量:5
  • 3张继春,金岩,李大魁,彭名炜.北京地区主要抗生素使用频度分析[J].中国药学杂志,1994,29(6):373-376. 被引量:34
  • 4刘屏,张志萍,陈宜鸿,孙映和,颜青,李辉.我院门诊处方中抗菌药物使用研究[J].中国药房,1995,6(2):23-24. 被引量:15
  • 5顾关云,蒋昱.植物降血糖成分的研究概况[J].国外医药(植物药分册),1997,12(2):55-60. 被引量:21
  • 6Qiang X,Satoh J,Sagara M,et al. Gluclazide inhibits diabetic neuropathy irrespective of blood glucose levels in streptozotocin-induced diabetic rats [J]. Metabolism,1998,47(8): 977-979.
  • 7Holman R R,Cull C A,Hurner R C. A randomized double-blind trial of acorbose in type 2 diabetes shows improved glycemic control over three years (UK prospective diabetes study 44) [J]. Diabetes Care,1999,22(6): 960-964.
  • 8Gomez-Perez F J,Fanghanel-Salmon G,Antonio-Barbosa J,et al. Efficacy and safety of rosiglitazone plus metformin in mexcans with type 2 diabetes[J]. Diabetes Metab Res Rev,2002,18(2): 127-129.
  • 9Lawrence I G. Rosiglitazone monotherapy and type 2 diabetes [J]. Diabetes Med,2001,18(Suppl 4): 6-8.
  • 10Kipnes K S,Krosnick A,Rendell M S,et al. Pioglitazone hydrochloride in combination with sulfonylure therapy improves glycemic control in treatment of patients with type 2 diabetes. a randomized,placebocontrolled study[J]. Am J Med,2001,111(1): 10-13.

共引文献1517

同被引文献29

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部